Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands.
SIR Institute for Pharmacy Practice and Policy, Theda Mansholtstraat 5B, Leiden, JE, 2331, The Netherlands.
Br J Clin Pharmacol. 2021 Mar;87(3):1282-1290. doi: 10.1111/bcp.14506. Epub 2020 Aug 14.
Associations between individual medication use and falling in older individuals are well-documented. However, a comprehensive risk score that takes into account overall medication use and that can be used in daily pharmacy practice is lacking. We, therefore, aimed to determine whether pharmacy dispensing records can be used to predict falls.
A retrospective cohort study was conducted using pharmacy dispensing data and self-reported falls among 3454 Dutch individuals aged ≥65 years. Two different methods were used to classify medication exposure for each person: the drug burden index (DBI) for cumulative anticholinergic and sedative medication exposure as well as exposure to fall risk-increasing drugs (FRIDs). Multinomial regression analyses, adjusted for age and sex, were conducted to investigate the association between medication exposure and falling classified as nonfalling, single falling and recurrent falling. The predictive performances of the DBI and FRIDs exposure were estimated by the polytomous discrimination index (PDI).
There were 521 single fallers (15%) and 485 recurrent fallers (14%). We found significant associations between a DBI ≥1 and single falling (adjusted odds ratio: 1.30 [95% confidence interval {CI}: 1.02-1.66]) and recurrent falling (adjusted odds ratio: 1.60 [95%CI: 1.25-2.04]). The PDI of the DBI model was 0.41 (95%CI: 0.39-0.42) and the PDI of the FRIDs model was 0.45 (95%CI: 0.43-0.47), indicating poor discrimination between fallers and nonfallers.
The study shows significant associations between medication use and falling. However, the medication-based models were insufficient and other factors should be included to develop a risk score for pharmacy practice.
个体用药与老年人跌倒之间的关联已有充分记录。然而,缺乏一种综合考虑整体用药情况并可用于日常药学实践的风险评分。因此,我们旨在确定药房配药记录是否可用于预测跌倒。
本研究采用回顾性队列研究,使用药房配药数据和 3454 名年龄≥65 岁的荷兰个体的自我报告跌倒数据。使用两种不同的方法对每个人的药物暴露情况进行分类:药物负担指数(DBI)用于累积抗胆碱能和镇静药物暴露以及增加跌倒风险的药物(FRIDs)暴露。使用多项回归分析,调整年龄和性别因素,研究药物暴露与跌倒的关联,跌倒情况分为未跌倒、单次跌倒和复发性跌倒。通过多项判别指数(PDI)估计 DBI 和 FRIDs 暴露的预测性能。
有 521 名单次跌倒者(15%)和 485 名复发性跌倒者(14%)。我们发现 DBI≥1 与单次跌倒(调整后的优势比:1.30 [95%置信区间 {CI}:1.02-1.66])和复发性跌倒(调整后的优势比:1.60 [95%CI:1.25-2.04])显著相关。DBI 模型的 PDI 为 0.41(95%CI:0.39-0.42),FRIDs 模型的 PDI 为 0.45(95%CI:0.43-0.47),表明跌倒者和非跌倒者之间的区分度较差。
本研究表明药物使用与跌倒之间存在显著关联。然而,基于药物的模型不够充分,应该纳入其他因素来开发用于药学实践的风险评分。